Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Infographic: Elsevier’s Professional Services team provides COVID-19 insights

Posted on May 1st, 2020 by in COVID-19

Check out a special infographic we created to show how Elsevier’s Professional Services team can support your COVID-19 research.

(more…)

Webinar: Accelerating drug discovery by building and turning high-quality data into actionable insights

Posted on April 6th, 2020 by in Chemistry

Drug discovery is a time-consuming and costly process (and all the more costly because it’s time-consuming). One of the hopes of the era of Big Data has been that having access to a wealth of scientific information could help speed the discovery process. However, the data itself has proven to come with many challenges. Medicinal chemists like myself are often frustrated in our attempts to integrate and work with disparate and unstructured sets of data.

(more…)

Personal Health Train initiative gives researchers data access FAIRly

Posted on March 19th, 2020 by in Pharma R&D

Health data is everywhere. It is managed by universities, research centers, medical institutions and by individuals themselves. With this valuable data located in so many disparate places, and organized differently in each place, it can be difficult for researchers to access and make use of it.

(more…)

FAIRification – don’t overthink it, just do it and tell others how

Posted on March 4th, 2020 by in Pharma R&D

Ideas change the world, but rarely without a lot of missteps, rethinking and redoing. The FAIR Data Principles are no exception: mostly, they emerged from ideas that were developed over the course of years before being consolidated and named in 2016, and now we’re in the thick of trying, learning, maturing.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6